0.028258
0.000000
0.000000
0.000000
0.028261
0.000000
0.000000
0.000000
0.009586
0.00000
0.00000
0.00000
Yadav, M.K.
Leman, L.J.
Price, D.J.
Brooks 3rd, C.L.
Stout, C.D.
Ghadiri, M.R.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
16
90.00
90.00
90.00
35.388
35.384
104.318
C2 H4 O
44.053
ACETYL GROUP
non-polymer
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
45
4463
4473
10.1021/bi060092q
16584182
Coiled coils at the edge of configurational heterogeneity. Structural analyses of parallel and antiparallel homotetrameric coiled coils reveal configurational sensitivity to a single solvent-exposed amino acid substitution.
2006
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
180.0
1
CCD
2004-05-20
ADSC CCD
SINGLE WAVELENGTH
M
x-ray
1
1.5418
1.0
1.5418
ROTATING ANODE
RIGAKU
4046.866
General control protein GCN4
RESIDUES 249-281
YES
2
syn
polymer
18.015
water
83
nat
water
Amino acid biosynthesis regulatory protein
no
yes
(ACE)RMKQIEDKLEEILSKLYHICNELARIKKLLGER
XRMKQIEDKLEEILSKLYHICNELARIKKLLGER
A,B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
1
1.93
35
10.50
100MM CAPS PH 10.5, 30% PEG 400
citation
citation_author
entity
entity_name_com
entity_src_nat
pdbx_entity_src_syn
struct_ref
struct_ref_seq
struct_ref_seq_dif
audit_author
citation_author
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Source and taxonomy
Structure summary
Data collection
Database references
Structure summary
1
0
2006-04-06
1
1
2011-05-08
1
2
2011-07-13
1
3
2018-09-19
1
4
2018-11-07
_citation.page_last
_citation.pdbx_database_id_DOI
_citation.title
_citation_author.name
_entity.pdbx_description
_entity.src_method
_entity_name_com.name
_audit_author.name
_citation_author.name
_struct_ref_seq_dif.details
2006-04-06
SPRSDE
HELIX CAPPING IN THE GCN4 LEUCINE ZIPPER
GCN4 LEUCINE ZIPPER COMPLEXED WITH SPECIFIC ATF/CREB SITE DEOXYRIBONUCLEIC ACID
ATOMIC STRUCTURE OF THE ECTODOMAIN FROM HIV -1 GP41
THE STRUCTURE OF AN HIV-1 SPECIFIC CELL ENTRY INHIBITOR INCOMPLEX WITH THE HIV-1 GP41 TRIMERIC CORE
GCN4 LEUCINE ZIPPER CORE MUTANT P-LI
GCN4 LEUCINE ZIPPER CORE MUTANT P-LI
HUMAN VIMENTIN COIL 2B FRAGMENT LINKED TO GCN4 LEUCINE ZIPPER (Z2B)
CRYSTAL STRUCTURE OF C14LINKMID/IQN17: A CROSS-LINKED INHIBITOR OF HIV-1 ENTRY BOUND TO THE GP41 HYDROPHOBIC POCKET
GLYTM1BZIP: A CHIMERIC PEPTIDE MODEL OF THE N-TERMINUS OF ARAT SHORT ALPHA TROPOMYOSIN WITH THE N-TERMINUS ENCODED BYEXON 1B
COILED COIL TRIMER GCN4-PVLS SER AT BURIED D POSITION
GCN4-PVLT COILED-COIL TRIMER WITH THREONINE AT THE D(12)POSITION
GCN4-PVTL COILED-COIL TRIMER WITH THREONINE AT THE A(16)POSITION
GCN4-PVSL COILED-COIL TRIMER WITH SERINE AT THE A(16)POSITION
CRYSTAL STRUCTURE OF THE C-TERMINAL REGION OF STRIATEDMUSCLE ALPHA-TROPOMYOSIN AT 2.7 ANGSTROM RESOLUTION
PLACEMENT OF THE STRUCTURAL PROTEINS IN SINDBIS VIRUS
CRYSTAL STRUCTURE OF A ZIF23-GCN4 CHIMERA BOUND TO DNA
VISUALIZING AN UNSTABLE COILED COIL: THE CRYSTAL STRUCTUREOF AN N-TERMINAL SEGMENT OF THE SCALLOP MYOSIN ROD
CRYSTAL STRUCTURE OF GCN4-PIQ, A TRIMERIC COILED COIL WITH BURIED POLAR RESIDUES
GCN4-LEUCINE ZIPPER CORE MUTANT AS N16A TRIGONAL AUTOMATICSOLUTION
ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TETRAGONAL AUTOMATIC SOLUTION
ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TRIGONAL FORM
ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TETRAGONAL FORM
GCN4-LEUCINE ZIPPER CORE MUTANT AS N16A COMPLEXED WITH BENZENE
TMZIP: A CHIMERIC PEPTIDE MODEL OF THE N- TERMINUS OF ALPHA TROPOMYOSIN, NMR, 15 STRUCTURES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
AN ANTI-PARALLEL FOUR HELIX BUNDLE MUTANT PLI-E20C
AN ANTI-PARALLEL FOUR HELIX BUNDLE ( ACETIMIDE MODIFICATION).
AN ANTI-PARALLEL FOUR HELIX BUNDLE.
ABA DOES NOT AFFECT TOPOLOGY OF PLI.
AN ANTI-PARALLEL FOUR HELIX BUNDLE
AN ANTI-PARALLEL FOUR HELIX BUNDLE
AN ANTI-PARALLEL TO PARALLEL SWITCH.
GCN4 (BASIC REGION, LEUCINE ZIPPER) COMPLEX WITH AP-1 DEOXYRIBONUCLEIC ACID
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16ABA IN THE DIMERIC STATE
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16ABA IN THE TRIMERIC STATE
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16LYS IN THE DIMERIC STATE
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16GLN IN THE DIMERIC STATE
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16GLN IN THE TRIMERIC STATE
LEUCINE ZIPPER MONOMER (NMR, 20 STRUCTURES)
PLI MUTANT E20C L16G Y17H, ANTIPARALLEL
PARALLEL CONFIGURATION OF PLI E20S
ANTIPARALLEL CONFIGURATION OF PLI E20S
GCN4 BASIC DOMAIN, LEUCINE ZIPPER COMPLEXED WITH ATF/CREB SITE DEOXYRIBONUCLEIC ACID
GCN4 LEUCINE ZIPPER
PDBE
Y
PDBE
2006-01-16
REL
HOH
water
4932
Baker's yeast
Saccharomyces cerevisiae
sample
1
34
ENGINEERED RESIDUE IN CHAIN A, GLU 268 TO CYS
ENGINEERED RESIDUE IN CHAIN B, GLU 268 TO CYS
HOH
2001
2
HOH
HOH
2001
A
HOH
2002
2
HOH
HOH
2002
A
HOH
2003
2
HOH
HOH
2003
A
HOH
2004
2
HOH
HOH
2004
A
HOH
2005
2
HOH
HOH
2005
A
HOH
2006
2
HOH
HOH
2006
A
HOH
2007
2
HOH
HOH
2007
A
HOH
2008
2
HOH
HOH
2008
A
HOH
2009
2
HOH
HOH
2009
A
HOH
2010
2
HOH
HOH
2010
A
HOH
2011
2
HOH
HOH
2011
A
HOH
2012
2
HOH
HOH
2012
A
HOH
2013
2
HOH
HOH
2013
A
HOH
2014
2
HOH
HOH
2014
A
HOH
2015
2
HOH
HOH
2015
A
HOH
2016
2
HOH
HOH
2016
A
HOH
2017
2
HOH
HOH
2017
A
HOH
2018
2
HOH
HOH
2018
A
HOH
2019
2
HOH
HOH
2019
A
HOH
2020
2
HOH
HOH
2020
A
HOH
2021
2
HOH
HOH
2021
A
HOH
2022
2
HOH
HOH
2022
A
HOH
2023
2
HOH
HOH
2023
A
HOH
2024
2
HOH
HOH
2024
A
HOH
2025
2
HOH
HOH
2025
A
HOH
2026
2
HOH
HOH
2026
A
HOH
2027
2
HOH
HOH
2027
A
HOH
2028
2
HOH
HOH
2028
A
HOH
2029
2
HOH
HOH
2029
A
HOH
2030
2
HOH
HOH
2030
A
HOH
2031
2
HOH
HOH
2031
A
HOH
2032
2
HOH
HOH
2032
A
HOH
2001
2
HOH
HOH
2001
B
HOH
2002
2
HOH
HOH
2002
B
HOH
2003
2
HOH
HOH
2003
B
HOH
2004
2
HOH
HOH
2004
B
HOH
2005
2
HOH
HOH
2005
B
HOH
2006
2
HOH
HOH
2006
B
HOH
2007
2
HOH
HOH
2007
B
HOH
2008
2
HOH
HOH
2008
B
HOH
2009
2
HOH
HOH
2009
B
HOH
2010
2
HOH
HOH
2010
B
HOH
2011
2
HOH
HOH
2011
B
HOH
2012
2
HOH
HOH
2012
B
HOH
2013
2
HOH
HOH
2013
B
HOH
2014
2
HOH
HOH
2014
B
HOH
2015
2
HOH
HOH
2015
B
HOH
2016
2
HOH
HOH
2016
B
HOH
2017
2
HOH
HOH
2017
B
HOH
2018
2
HOH
HOH
2018
B
HOH
2019
2
HOH
HOH
2019
B
HOH
2020
2
HOH
HOH
2020
B
HOH
2021
2
HOH
HOH
2021
B
HOH
2022
2
HOH
HOH
2022
B
HOH
2023
2
HOH
HOH
2023
B
HOH
2024
2
HOH
HOH
2024
B
HOH
2025
2
HOH
HOH
2025
B
HOH
2026
2
HOH
HOH
2026
B
HOH
2027
2
HOH
HOH
2027
B
HOH
2028
2
HOH
HOH
2028
B
HOH
2029
2
HOH
HOH
2029
B
HOH
2030
2
HOH
HOH
2030
B
HOH
2031
2
HOH
HOH
2031
B
HOH
2032
2
HOH
HOH
2032
B
HOH
2033
2
HOH
HOH
2033
B
HOH
2034
2
HOH
HOH
2034
B
HOH
2035
2
HOH
HOH
2035
B
HOH
2036
2
HOH
HOH
2036
B
HOH
2037
2
HOH
HOH
2037
B
HOH
2038
2
HOH
HOH
2038
B
HOH
2039
2
HOH
HOH
2039
B
HOH
2040
2
HOH
HOH
2040
B
HOH
2041
2
HOH
HOH
2041
B
HOH
2042
2
HOH
HOH
2042
B
HOH
2043
2
HOH
HOH
2043
B
HOH
2044
2
HOH
HOH
2044
B
HOH
2045
2
HOH
HOH
2045
B
HOH
2046
2
HOH
HOH
2046
B
HOH
2047
2
HOH
HOH
2047
B
HOH
2048
2
HOH
HOH
2048
B
HOH
2049
2
HOH
HOH
2049
B
HOH
2050
2
HOH
HOH
2050
B
HOH
2051
2
HOH
HOH
2051
B
n
1
0
A
ARG
1
n
2
ARG
1
A
MET
2
n
3
MET
2
A
LYS
3
n
4
LYS
3
A
GLN
4
n
5
GLN
4
A
ILE
5
n
6
ILE
5
A
GLU
6
n
7
GLU
6
A
ASP
7
n
8
ASP
7
A
LYS
8
n
9
LYS
8
A
LEU
9
n
10
LEU
9
A
GLU
10
n
11
GLU
10
A
GLU
11
n
12
GLU
11
A
ILE
12
n
13
ILE
12
A
LEU
13
n
14
LEU
13
A
SER
14
n
15
SER
14
A
LYS
15
n
16
LYS
15
A
LEU
16
n
17
LEU
16
A
TYR
17
n
18
TYR
17
A
HIS
18
n
19
HIS
18
A
ILE
19
n
20
ILE
19
A
CYS
20
n
21
CYS
20
A
ASN
21
n
22
ASN
21
A
GLU
22
n
23
GLU
22
A
LEU
23
n
24
LEU
23
A
ALA
24
n
25
ALA
24
A
ARG
25
n
26
ARG
25
A
ILE
26
n
27
ILE
26
A
LYS
27
n
28
LYS
27
A
LYS
28
n
29
LYS
28
A
LEU
29
n
30
LEU
29
A
LEU
30
n
31
LEU
30
A
GLY
31
n
32
GLY
31
A
GLU
32
n
33
GLU
32
A
ARG
33
n
34
ARG
33
A
n
1
0
B
ARG
1
n
2
ARG
1
B
MET
2
n
3
MET
2
B
LYS
3
n
4
LYS
3
B
GLN
4
n
5
GLN
4
B
ILE
5
n
6
ILE
5
B
GLU
6
n
7
GLU
6
B
ASP
7
n
8
ASP
7
B
LYS
8
n
9
LYS
8
B
LEU
9
n
10
LEU
9
B
GLU
10
n
11
GLU
10
B
GLU
11
n
12
GLU
11
B
ILE
12
n
13
ILE
12
B
LEU
13
n
14
LEU
13
B
SER
14
n
15
SER
14
B
LYS
15
n
16
LYS
15
B
LEU
16
n
17
LEU
16
B
TYR
17
n
18
TYR
17
B
HIS
18
n
19
HIS
18
B
ILE
19
n
20
ILE
19
B
CYS
20
n
21
CYS
20
B
ASN
21
n
22
ASN
21
B
GLU
22
n
23
GLU
22
B
LEU
23
n
24
LEU
23
B
ALA
24
n
25
ALA
24
B
ARG
25
n
26
ARG
25
B
ILE
26
n
27
ILE
26
B
LYS
27
n
28
LYS
27
B
LYS
28
n
29
LYS
28
B
LEU
29
n
30
LEU
29
B
LEU
30
n
31
LEU
30
B
GLY
31
n
32
GLY
31
B
GLU
32
n
33
GLU
32
B
ARG
33
n
34
ARG
33
B
author_and_software_defined_assembly
PQS
4
tetrameric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
2_765
-x+2,-y+1,z
crystal symmetry operation
70.7760000000
35.3840000000
0.0000000000
1
A
HOH
2020
C
HOH
1
A
N
ARG
1
A
N
ARG
2
1
Y
1
A
CA
ARG
1
A
CA
ARG
2
1
Y
1
A
CB
ARG
1
A
CB
ARG
2
1
Y
1
A
CG
ARG
1
A
CG
ARG
2
1
Y
1
A
CD
ARG
1
A
CD
ARG
2
1
Y
1
A
NE
ARG
1
A
NE
ARG
2
1
Y
1
A
CZ
ARG
1
A
CZ
ARG
2
1
Y
1
A
NH1
ARG
1
A
NH1
ARG
2
1
Y
1
A
NH2
ARG
1
A
NH2
ARG
2
1
Y
1
A
CD
LYS
3
A
CD
LYS
4
1
Y
1
A
CE
LYS
3
A
CE
LYS
4
1
Y
1
A
NZ
LYS
3
A
NZ
LYS
4
1
Y
1
A
CD
GLN
4
A
CD
GLN
5
1
Y
1
A
OE1
GLN
4
A
OE1
GLN
5
1
Y
1
A
NE2
GLN
4
A
NE2
GLN
5
1
Y
1
A
CE
LYS
28
A
CE
LYS
29
1
Y
1
A
NZ
LYS
28
A
NZ
LYS
29
1
Y
1
A
CZ
ARG
33
A
CZ
ARG
34
1
Y
1
A
NH1
ARG
33
A
NH1
ARG
34
1
Y
1
A
NH2
ARG
33
A
NH2
ARG
34
1
Y
1
B
NZ
LYS
3
B
NZ
LYS
4
1
Y
1
B
CG
GLN
4
B
CG
GLN
5
1
Y
1
B
CD
GLN
4
B
CD
GLN
5
1
Y
1
B
OE1
GLN
4
B
OE1
GLN
5
1
Y
1
B
NE2
GLN
4
B
NE2
GLN
5
1
Y
1
B
CD
ARG
25
B
CD
ARG
26
1
Y
1
B
NE
ARG
25
B
NE
ARG
26
1
Y
1
B
CZ
ARG
25
B
CZ
ARG
26
1
Y
1
B
NH1
ARG
25
B
NH1
ARG
26
1
Y
1
B
NH2
ARG
25
B
NH2
ARG
26
1
Y
1
B
CD
LYS
28
B
CD
LYS
29
1
Y
1
B
CE
LYS
28
B
CE
LYS
29
1
Y
1
B
NZ
LYS
28
B
NZ
LYS
29
1
Y
1
B
CB
ARG
33
B
CB
ARG
34
1
Y
1
B
CG
ARG
33
B
CG
ARG
34
1
Y
1
B
CD
ARG
33
B
CD
ARG
34
1
Y
1
B
NE
ARG
33
B
NE
ARG
34
1
Y
1
B
CZ
ARG
33
B
CZ
ARG
34
1
Y
1
B
NH1
ARG
33
B
NH1
ARG
34
1
Y
1
B
NH2
ARG
33
B
NH2
ARG
34
1
Y
1
A
ACE
0
A
ACE
1
1
Y
1
B
ACE
0
B
ACE
1
1
Y
1
B
B
O
O
HOH
HOH
2010
2011
1.90
1
A
A
O
O
HOH
HOH
2002
2004
1.96
1
B
B
O
O
HOH
HOH
2009
2020
1.99
1
B
B
CD
O
ARG
HOH
1
2003
2.11
1
B
B
N
O
ARG
HOH
1
2001
2.12
1
A
HIS
18
0.076
SIDE CHAIN
1
12.87
1.60
100.20
113.07
A
A
A
CG
SD
CE
MET
MET
MET
2
2
2
N
1
-5.48
0.90
118.30
112.82
A
A
A
CB
CG
OD2
ASP
ASP
ASP
7
7
7
N
1
-3.72
0.60
121.00
117.28
A
A
A
CB
CG
CD1
TYR
TYR
TYR
17
17
17
N
1
3.21
0.50
120.30
123.51
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
25
25
25
N
1
-3.06
0.50
120.30
117.24
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
25
25
25
N
1
-7.02
0.90
118.30
111.28
B
B
B
CB
CG
OD2
ASP
ASP
ASP
7
7
7
N
1
-3.82
0.60
121.00
117.18
B
B
B
CB
CG
CD2
TYR
TYR
TYR
17
17
17
N
1
20.10
2.30
115.30
135.40
B
B
B
CA
CB
CG
LEU
LEU
LEU
29
29
29
N
1
13.87
1.70
111.00
124.87
B
B
B
CB
CG
CD2
LEU
LEU
LEU
29
29
29
N
1
-11.15
1.70
111.00
99.85
B
B
B
CB
CG
CD1
LEU
LEU
LEU
30
30
30
N
1
A
A
CG
SD
MET
MET
2
2
0.162
0.026
1.807
1.969
N
1
A
A
CB
CG
TYR
TYR
17
17
-0.101
0.015
1.512
1.411
N
1
A
A
CG
CD2
TYR
TYR
17
17
-0.099
0.013
1.387
1.288
N
1
A
A
CE1
CZ
TYR
TYR
17
17
-0.093
0.013
1.381
1.288
N
1
A
A
CD
OE1
GLU
GLU
32
32
0.076
0.011
1.252
1.328
N
1
B
B
CG
CD1
TYR
TYR
17
17
-0.141
0.013
1.387
1.246
N
17.75
0.66000
0.00000
0.00000
0.66000
0.00000
-1.32000
0.952
0.929
HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. N TERMINUS OF PEPTIDE IS ACETYLATED WITH ACETIC ANHYDRIDE.
0.259
0.217
0.219
1.60
51.99
447
8913
4.800
99.6
1.572
0.056
RANDOM
1
THROUGHOUT
2.000
MOLECULAR REPLACEMENT
0.108
0.110
0.80
0.80
1.40
MAXIMUM LIKELIHOOD
BABINET MODEL WITH MASK
1.60
51.99
83
603
0
0
520
0.4520
0.3770
1.64
35
605
20
1.600
34.770
2CCN
9395
2.000
0.03000
1
27.1000
5.290
100.0
refinement
REFMAC
5.1.24
data reduction
CrystalClear
data scaling
CrystalClear
GENERAL CONTROL PROTEIN GCN4
pLI E20C is antiparallel
1
N
N
1
N
N
2
N
N
2
N
N
A
MET
2
A
MET
3
HELX_P
A
GLU
32
A
GLU
33
1
1
31
B
ARG
1
B
ARG
2
HELX_P
B
GLU
32
B
GLU
33
1
2
32
FOUR HELIX BUNDLE
FOUR HELIX BUNDLE, ANTIPARALLEL, PARALLEL, PLI, DNA-BINDING, NUCLEAR PROTEIN, TRANSCRIPTION, TRANSCRIPTION REGULATION, ACTIVATOR, AMINO-ACID BIOSYNTHESIS
GCN4_YEAST
UNP
1
249
P03069
RMKQLEDKVEELLSKNYHLENEVARLKKLVGER
249
281
2CCN
1
33
P03069
A
1
2
34
249
281
2CCN
1
33
P03069
B
1
2
34
1
expression tag
ACE
0
2CCN
A
P03069
UNP
1
1
LEU
engineered mutation
ILE
5
2CCN
A
P03069
UNP
253
6
1
VAL
engineered mutation
LEU
9
2CCN
A
P03069
UNP
257
10
1
LEU
engineered mutation
ILE
12
2CCN
A
P03069
UNP
260
13
1
ASN
engineered mutation
LEU
16
2CCN
A
P03069
UNP
264
17
1
LEU
engineered mutation
ILE
19
2CCN
A
P03069
UNP
267
20
1
GLU
engineered mutation
CYS
20
2CCN
A
P03069
UNP
268
21
1
VAL
engineered mutation
LEU
23
2CCN
A
P03069
UNP
271
24
1
LEU
engineered mutation
ILE
26
2CCN
A
P03069
UNP
274
27
1
VAL
engineered mutation
LEU
30
2CCN
A
P03069
UNP
278
31
2
expression tag
ACE
0
2CCN
B
P03069
UNP
1
2
LEU
engineered mutation
ILE
5
2CCN
B
P03069
UNP
253
6
2
VAL
engineered mutation
LEU
9
2CCN
B
P03069
UNP
257
10
2
LEU
engineered mutation
ILE
12
2CCN
B
P03069
UNP
260
13
2
ASN
engineered mutation
LEU
16
2CCN
B
P03069
UNP
264
17
2
LEU
engineered mutation
ILE
19
2CCN
B
P03069
UNP
267
20
2
GLU
engineered mutation
CYS
20
2CCN
B
P03069
UNP
268
21
2
VAL
engineered mutation
LEU
23
2CCN
B
P03069
UNP
271
24
2
LEU
engineered mutation
ILE
26
2CCN
B
P03069
UNP
274
27
2
VAL
engineered mutation
LEU
30
2CCN
B
P03069
UNP
278
31
94
P 42 21 2